Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT00004179




Registration number
NCT00004179
Ethics application status
Date submitted
21/01/2000
Date registered
27/01/2003
Date last updated
15/02/2021

Titles & IDs
Public title
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Scientific title
Chimeric Anti-CD20 Monoclonal Antibody (Mabthera) in Remission Induction and Maintenance Treatment of Relapsed Follicular Non-Hodgkin's Lymphoma: A Phase III Randomized Clinical Trial - Intergroup Collaborative Study
Secondary ID [1] 0 0
EORTC-20981
Secondary ID [2] 0 0
EORTC-20981
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Lymphoma 0 0
Condition category
Condition code
Cancer 0 0 0 0
Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma
Cancer 0 0 0 0
Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Response to treatment
Timepoint [1] 0 0
Secondary outcome [1] 0 0
Overall survival
Timepoint [1] 0 0
from randomization
Secondary outcome [2] 0 0
Progression Free survival
Timepoint [2] 0 0
from randomization

Eligibility
Key inclusion criteria
DISEASE CHARACTERISTICS:

* Histologically or cytologically proven stage III or IV follicular non-Hodgkin's lymphoma (NHL)

* Relapsed after or no response (no change/progressive disease) to no more than 2 adequate non-anthracycline-containing systemic chemotherapy regimens
* At least 2 months of single-agent therapy (e.g., chlorambucil) AND/OR
* At least 2 consecutive courses of polychemotherapy (e.g., cyclophosphamide, vincristine, and prednisone) or purine analogues
* Complete or partial remission or no change for at least 4 weeks after completion of prior therapy OR progression during one of a maximum of 2 prior therapy regimens
* CD20 positive
* At least 1 bidimensionally measurable mass
* No greater than 10,000,000/mL circulating tumor cells
* IgG levels at least 3 g/L
* No low-grade NHL transformed into intermediate- or high-grade NHL
* No symptomatic CNS lymphoma
* No bone marrow involvement only NOTE: A new classification scheme for adult non-Hodgkin's lymphoma has been adopted by PDQ. The terminology of "indolent" or "aggressive" lymphoma will replace the former terminology of "low", "intermediate", or "high" grade lymphoma. However, this protocol uses the former terminology.

PATIENT CHARACTERISTICS:

Age:

* 18 and over

Performance status:

* WHO 0-2

Life expectancy:

* Not specified

Hematopoietic:

* Not specified

Hepatic:

* Bilirubin less than 2.5 times upper limit of normal (ULN)
* Alkaline phosphatase less than 2.5 times ULN

Renal:

* Creatinine less than 2.5 times ULN
* BUN less than 2.5 times ULN

Cardiovascular:

* No severe cardiac disease (i.e., severe heart failure requiring symptomatic treatment)

Pulmonary:

* No severe pulmonary disease

Other:

* No severe neurologic or psychiatric disease
* No severe metabolic disease
* Not pregnant
* Fertile patients must use effective contraception
* No prior malignancy within the past 5 years except nonmelanomatous skin cancer, carcinoma in situ of the cervix, or other cancer curatively treated with surgical therapy
* HIV negative
* No uncontrolled asthma or allergy requiring steroids
* No known hypersensitivity or prior anaphylactic reaction to murine proteins or any component of study drug

PRIOR CONCURRENT THERAPY:

Biologic therapy:

* No prior rituximab
* No prior allogeneic or autologous peripheral blood stem cell transplantation
* Concurrent filgrastim (G-CSF) for stem cell mobilization allowed

Chemotherapy:

* See Disease Characteristics
* No prior anthracyclines or mitoxantrone
* No concurrent chemotherapy for stem cell mobilization

Endocrine therapy:

* Not specified

Radiotherapy:

* Not specified

Surgery:

* Not specified
Minimum age
18 Years
Maximum age
120 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/05/1999
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
19/07/2017
Sample size
Target
Accrual to date
Final
475
Recruitment in Australia
Recruitment state(s)
ACT,NSW,QLD,SA,TAS,VIC,WA
Recruitment hospital [1] 0 0
Canberra Hospital - Garran
Recruitment hospital [2] 0 0
Concord Repatriation General Hospital - Concord
Recruitment hospital [3] 0 0
Cancer Therapy Centre at Liverpool Hospital - Liverpool
Recruitment hospital [4] 0 0
Institute of Oncology at Prince of Wales Hospital - Randwick
Recruitment hospital [5] 0 0
Prince of Wales Private Hospital - Randwick
Recruitment hospital [6] 0 0
Royal North Shore Hospital - St. Leonards
Recruitment hospital [7] 0 0
St. Vincent's Hospital - Sydney
Recruitment hospital [8] 0 0
Sydney Cancer Centre at Royal Prince Alfred Hospital - Sydney
Recruitment hospital [9] 0 0
St. George Hospital and Community Health Service - Sydney
Recruitment hospital [10] 0 0
Westmead Breast Centre at NSW Breast Cancer Institute - Westmead
Recruitment hospital [11] 0 0
Westmead Hospital - Westmead
Recruitment hospital [12] 0 0
Wollongong Hospital - Wollongong
Recruitment hospital [13] 0 0
Wesley Medical Centre - Auchenflower
Recruitment hospital [14] 0 0
Royal Brisbane and Women's Hospital - Brisbane
Recruitment hospital [15] 0 0
Princess Alexandra Hospital - Brisbane
Recruitment hospital [16] 0 0
Greenslopes Private Hospital - Greenslopes
Recruitment hospital [17] 0 0
Townsville General Hospital - Townsville
Recruitment hospital [18] 0 0
Royal Adelaide Hospital Cancer Centre - Adelaide
Recruitment hospital [19] 0 0
Ashford Cancer Centre - Ashford
Recruitment hospital [20] 0 0
Flinder Medical Centres - Bedford Park
Recruitment hospital [21] 0 0
Queen Elizabeth Hospital - Woodville
Recruitment hospital [22] 0 0
Royal Hobart Hospital - Hobart
Recruitment hospital [23] 0 0
St. John of God Hospital - Ballarat
Recruitment hospital [24] 0 0
Box Hill Hospital - Box Hill
Recruitment hospital [25] 0 0
John Fawkner Hospital - Coburg
Recruitment hospital [26] 0 0
Peter MacCallum Cancer Centre - East Melbourne
Recruitment hospital [27] 0 0
St. Vincent's Hospital - Fitzroy
Recruitment hospital [28] 0 0
Frankston Hospital - Frankston
Recruitment hospital [29] 0 0
Geelong Hospital - Geelong
Recruitment hospital [30] 0 0
Austin Hospital - Heidelberg
Recruitment hospital [31] 0 0
Alfred Hospital - Melbourne
Recruitment hospital [32] 0 0
Garden Consulting Rooms - Mornington
Recruitment hospital [33] 0 0
Royal Melbourne Hospital - Parkville
Recruitment hospital [34] 0 0
Fremantle Hospital - Fremantle
Recruitment hospital [35] 0 0
Mount Medical Centre - Perth
Recruitment hospital [36] 0 0
Royal Perth Hospital - Perth
Recruitment hospital [37] 0 0
Sir Charles Gairdner Hospital - Perth - Perth
Recruitment postcode(s) [1] 0 0
2605 - Garran
Recruitment postcode(s) [2] 0 0
2139 - Concord
Recruitment postcode(s) [3] 0 0
2170 - Liverpool
Recruitment postcode(s) [4] 0 0
2031 - Randwick
Recruitment postcode(s) [5] 0 0
NSW 2031 - Randwick
Recruitment postcode(s) [6] 0 0
2065 - St. Leonards
Recruitment postcode(s) [7] 0 0
2010 - Sydney
Recruitment postcode(s) [8] 0 0
2050 - Sydney
Recruitment postcode(s) [9] 0 0
2217 - Sydney
Recruitment postcode(s) [10] 0 0
2145 - Westmead
Recruitment postcode(s) [11] 0 0
2500 - Wollongong
Recruitment postcode(s) [12] 0 0
4066 - Auchenflower
Recruitment postcode(s) [13] 0 0
4029 - Brisbane
Recruitment postcode(s) [14] 0 0
4102 - Brisbane
Recruitment postcode(s) [15] 0 0
4120 - Greenslopes
Recruitment postcode(s) [16] 0 0
4810 - Townsville
Recruitment postcode(s) [17] 0 0
5000 - Adelaide
Recruitment postcode(s) [18] 0 0
5035 - Ashford
Recruitment postcode(s) [19] 0 0
5042 - Bedford Park
Recruitment postcode(s) [20] 0 0
5011 - Woodville
Recruitment postcode(s) [21] 0 0
7000 - Hobart
Recruitment postcode(s) [22] 0 0
3350 - Ballarat
Recruitment postcode(s) [23] 0 0
3128 - Box Hill
Recruitment postcode(s) [24] 0 0
3058 - Coburg
Recruitment postcode(s) [25] 0 0
8006 - East Melbourne
Recruitment postcode(s) [26] 0 0
3065 - Fitzroy
Recruitment postcode(s) [27] 0 0
3199 - Frankston
Recruitment postcode(s) [28] 0 0
3200 - Geelong
Recruitment postcode(s) [29] 0 0
3084 - Heidelberg
Recruitment postcode(s) [30] 0 0
3181 - Melbourne
Recruitment postcode(s) [31] 0 0
3931 - Mornington
Recruitment postcode(s) [32] 0 0
3050 - Parkville
Recruitment postcode(s) [33] 0 0
6160 - Fremantle
Recruitment postcode(s) [34] 0 0
6000 - Perth
Recruitment postcode(s) [35] 0 0
6009 - Perth
Recruitment outside Australia
Country [1] 0 0
Belgium
State/province [1] 0 0
Antwerp
Country [2] 0 0
Belgium
State/province [2] 0 0
Brussels
Country [3] 0 0
Belgium
State/province [3] 0 0
Edegem
Country [4] 0 0
Belgium
State/province [4] 0 0
Ghent
Country [5] 0 0
Belgium
State/province [5] 0 0
Leuven
Country [6] 0 0
Belgium
State/province [6] 0 0
Roeselare
Country [7] 0 0
Belgium
State/province [7] 0 0
Wilrijk
Country [8] 0 0
Canada
State/province [8] 0 0
Alberta
Country [9] 0 0
Canada
State/province [9] 0 0
British Columbia
Country [10] 0 0
Canada
State/province [10] 0 0
Manitoba
Country [11] 0 0
Canada
State/province [11] 0 0
New Brunswick
Country [12] 0 0
Canada
State/province [12] 0 0
Newfoundland and Labrador
Country [13] 0 0
Canada
State/province [13] 0 0
Nova Scotia
Country [14] 0 0
Canada
State/province [14] 0 0
Ontario
Country [15] 0 0
Canada
State/province [15] 0 0
Quebec
Country [16] 0 0
Canada
State/province [16] 0 0
Saskatchewan
Country [17] 0 0
Denmark
State/province [17] 0 0
Copenhagen
Country [18] 0 0
Denmark
State/province [18] 0 0
Vejle
Country [19] 0 0
Egypt
State/province [19] 0 0
Cairo
Country [20] 0 0
France
State/province [20] 0 0
Bordeaux
Country [21] 0 0
France
State/province [21] 0 0
Villejuif
Country [22] 0 0
Hungary
State/province [22] 0 0
Budapest
Country [23] 0 0
Italy
State/province [23] 0 0
Aviano
Country [24] 0 0
Netherlands
State/province [24] 0 0
's-Gravenhage
Country [25] 0 0
Netherlands
State/province [25] 0 0
's-Hertogenbosch
Country [26] 0 0
Netherlands
State/province [26] 0 0
Alkmaar
Country [27] 0 0
Netherlands
State/province [27] 0 0
Almere
Country [28] 0 0
Netherlands
State/province [28] 0 0
Amersfont
Country [29] 0 0
Netherlands
State/province [29] 0 0
Amsterdam
Country [30] 0 0
Netherlands
State/province [30] 0 0
Apeldoorn
Country [31] 0 0
Netherlands
State/province [31] 0 0
Bergen-op-Zoom
Country [32] 0 0
Netherlands
State/province [32] 0 0
Blaricum
Country [33] 0 0
Netherlands
State/province [33] 0 0
Breda
Country [34] 0 0
Netherlands
State/province [34] 0 0
Brunssum
Country [35] 0 0
Netherlands
State/province [35] 0 0
Capelle aan den Ijssel
Country [36] 0 0
Netherlands
State/province [36] 0 0
Delft
Country [37] 0 0
Netherlands
State/province [37] 0 0
Den Haag
Country [38] 0 0
Netherlands
State/province [38] 0 0
Den Helder
Country [39] 0 0
Netherlands
State/province [39] 0 0
Deventer
Country [40] 0 0
Netherlands
State/province [40] 0 0
Dirksland
Country [41] 0 0
Netherlands
State/province [41] 0 0
Drachten
Country [42] 0 0
Netherlands
State/province [42] 0 0
Eindhoven
Country [43] 0 0
Netherlands
State/province [43] 0 0
Enschede
Country [44] 0 0
Netherlands
State/province [44] 0 0
Geldrop
Country [45] 0 0
Netherlands
State/province [45] 0 0
Gorinchem
Country [46] 0 0
Netherlands
State/province [46] 0 0
Gouda
Country [47] 0 0
Netherlands
State/province [47] 0 0
Groningen
Country [48] 0 0
Netherlands
State/province [48] 0 0
Haarlem
Country [49] 0 0
Netherlands
State/province [49] 0 0
Harderwijk
Country [50] 0 0
Netherlands
State/province [50] 0 0
Heerenveen
Country [51] 0 0
Netherlands
State/province [51] 0 0
Heerlen
Country [52] 0 0
Netherlands
State/province [52] 0 0
Helmond
Country [53] 0 0
Netherlands
State/province [53] 0 0
Hengelo
Country [54] 0 0
Netherlands
State/province [54] 0 0
Hoorn
Country [55] 0 0
Netherlands
State/province [55] 0 0
La Zierikzee
Country [56] 0 0
Netherlands
State/province [56] 0 0
Leeuwarden
Country [57] 0 0
Netherlands
State/province [57] 0 0
Leiden
Country [58] 0 0
Netherlands
State/province [58] 0 0
Leiderdorp
Country [59] 0 0
Netherlands
State/province [59] 0 0
Leidschendam
Country [60] 0 0
Netherlands
State/province [60] 0 0
Maastricht
Country [61] 0 0
Netherlands
State/province [61] 0 0
Meppel
Country [62] 0 0
Netherlands
State/province [62] 0 0
Nieuwegein
Country [63] 0 0
Netherlands
State/province [63] 0 0
Nijmegen
Country [64] 0 0
Netherlands
State/province [64] 0 0
Oss
Country [65] 0 0
Netherlands
State/province [65] 0 0
Purmerend
Country [66] 0 0
Netherlands
State/province [66] 0 0
Roermond
Country [67] 0 0
Netherlands
State/province [67] 0 0
Roosendaal
Country [68] 0 0
Netherlands
State/province [68] 0 0
Rotterdam
Country [69] 0 0
Netherlands
State/province [69] 0 0
Sittard
Country [70] 0 0
Netherlands
State/province [70] 0 0
Sliedrecht
Country [71] 0 0
Netherlands
State/province [71] 0 0
Spykenisse
Country [72] 0 0
Netherlands
State/province [72] 0 0
Stadskanaal
Country [73] 0 0
Netherlands
State/province [73] 0 0
Terneuzen
Country [74] 0 0
Netherlands
State/province [74] 0 0
Tiel
Country [75] 0 0
Netherlands
State/province [75] 0 0
Tilburg
Country [76] 0 0
Netherlands
State/province [76] 0 0
Utrecht
Country [77] 0 0
Netherlands
State/province [77] 0 0
Veghel
Country [78] 0 0
Netherlands
State/province [78] 0 0
Veldhoven
Country [79] 0 0
Netherlands
State/province [79] 0 0
Vlaardingen
Country [80] 0 0
Netherlands
State/province [80] 0 0
Voorburg
Country [81] 0 0
Netherlands
State/province [81] 0 0
Weert Be
Country [82] 0 0
Netherlands
State/province [82] 0 0
Woerden
Country [83] 0 0
Netherlands
State/province [83] 0 0
Zaandam
Country [84] 0 0
Netherlands
State/province [84] 0 0
Zeist
Country [85] 0 0
Netherlands
State/province [85] 0 0
Zoetermeer
Country [86] 0 0
Netherlands
State/province [86] 0 0
Zwolle
Country [87] 0 0
New Zealand
State/province [87] 0 0
Auckland
Country [88] 0 0
New Zealand
State/province [88] 0 0
Christchurch
Country [89] 0 0
New Zealand
State/province [89] 0 0
Hamilton
Country [90] 0 0
Norway
State/province [90] 0 0
Bergen
Country [91] 0 0
Norway
State/province [91] 0 0
Oslo
Country [92] 0 0
Norway
State/province [92] 0 0
Trondheim
Country [93] 0 0
Poland
State/province [93] 0 0
Warsaw
Country [94] 0 0
Portugal
State/province [94] 0 0
Lisbon
Country [95] 0 0
Slovakia
State/province [95] 0 0
Bratislava
Country [96] 0 0
Slovenia
State/province [96] 0 0
Ljubljana
Country [97] 0 0
South Africa
State/province [97] 0 0
Brooklyn Square
Country [98] 0 0
South Africa
State/province [98] 0 0
Johannesburg
Country [99] 0 0
South Africa
State/province [99] 0 0
Parktown
Country [100] 0 0
Sweden
State/province [100] 0 0
Gothenburg (Goteborg)
Country [101] 0 0
Sweden
State/province [101] 0 0
Linkoping
Country [102] 0 0
Sweden
State/province [102] 0 0
Lulea
Country [103] 0 0
Sweden
State/province [103] 0 0
Lund
Country [104] 0 0
Sweden
State/province [104] 0 0
Orebro
Country [105] 0 0
Sweden
State/province [105] 0 0
Stockholm
Country [106] 0 0
Sweden
State/province [106] 0 0
Sundsvall
Country [107] 0 0
Sweden
State/province [107] 0 0
Umea
Country [108] 0 0
United Kingdom
State/province [108] 0 0
England
Country [109] 0 0
United Kingdom
State/province [109] 0 0
Northern Ireland
Country [110] 0 0
United Kingdom
State/province [110] 0 0
Scotland
Country [111] 0 0
United Kingdom
State/province [111] 0 0
Wales
Country [112] 0 0
United Kingdom
State/province [112] 0 0
Chichester
Country [113] 0 0
United Kingdom
State/province [113] 0 0
Hull
Country [114] 0 0
United Kingdom
State/province [114] 0 0
Kettering, Northants
Country [115] 0 0
United Kingdom
State/province [115] 0 0
Stafford
Country [116] 0 0
United Kingdom
State/province [116] 0 0
Swindon,

Funding & Sponsors
Primary sponsor type
Other
Name
European Organisation for Research and Treatment of Cancer - EORTC
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
Lymphoma Trials Office
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
Stichting Hemato-Oncologie voor Volwassenen Nederland
Address [2] 0 0
Country [2] 0 0
Other collaborator category [3] 0 0
Other
Name [3] 0 0
Australasian Leukaemia and Lymphoma Group
Address [3] 0 0
Country [3] 0 0
Other collaborator category [4] 0 0
Other
Name [4] 0 0
NCIC Clinical Trials Group
Address [4] 0 0
Country [4] 0 0
Other collaborator category [5] 0 0
Other
Name [5] 0 0
Nordic Lymphoma Group
Address [5] 0 0
Country [5] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. It is not yet known whether chemotherapy is more effective with or without rituximab for relapsed non-Hodgkin's lymphoma.

PURPOSE: This randomized phase III trial is studying combination chemotherapy and rituximab to see how well they work compared to combination chemotherapy alone in treating patients with relapsed non-Hodgkin's lymphoma.
Trial website
https://clinicaltrials.gov/study/NCT00004179
Trial related presentations / publications
Deconinck E, Miadi-Fargier H, Pen CL, Brice P. Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluation. Pharmacoeconomics. 2010;28(1):35-46. doi: 10.2165/11314070-000000000-00000.
Pompen M, Huijgens PC, et al.: Cost-effectiveness of rituximab for maintenance in patients with follicular non-Hodgkin's lymphoma in the Dutch setting. [Abstract] Blood 112 (11): A-2364, 2008.
Van Oers MH, Hagenbeek A, Van Glabbeke M, Teodorovic I. Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study. Ann Hematol. 2002 Oct;81(10):553-7. doi: 10.1007/s00277-002-0548-2. Epub 2002 Oct 17. No abstract available.
van Oers MH, Tonnissen E, Van Glabbeke M, Giurgea L, Jansen JH, Klasa R, Marcus RE, Wolf M, Kimby E, Vranovsky A, Holte H, Hagenbeek A, van der Reijden BA. BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study. J Clin Oncol. 2010 May 1;28(13):2246-52. doi: 10.1200/JCO.2009.25.0852. Epub 2010 Apr 5.
van Oers MH, Van Glabbeke M, Giurgea L, Klasa R, Marcus RE, Wolf M, Kimby E, van t Veer M, Vranovsky A, Holte H, Hagenbeek A. Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study. J Clin Oncol. 2010 Jun 10;28(17):2853-8. doi: 10.1200/JCO.2009.26.5827. Epub 2010 May 3.
van Oers MH, Klasa R, Marcus RE, Wolf M, Kimby E, Gascoyne RD, Jack A, Van't Veer M, Vranovsky A, Holte H, van Glabbeke M, Teodorovic I, Rozewicz C, Hagenbeek A. Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial. Blood. 2006 Nov 15;108(10):3295-301. doi: 10.1182/blood-2006-05-021113. Epub 2006 Jul 27.
Mattiola I, Mantovani A, Locati M. The tetraspan MS4A family in homeostasis, immunity, and disease. Trends Immunol. 2021 Sep;42(9):764-781. doi: 10.1016/j.it.2021.07.002. Epub 2021 Aug 9.
Public notes

Contacts
Principal investigator
Name 0 0
M. H. J. Van Oers, MD
Address 0 0
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT00004179